By Frank Prenesti
Date: Tuesday 11 Oct 2022
(Sharecast News) - Shares in healthcare company PureTech fell on Tuesday as the company said it and US-based Nektar Therapeutics had ended merger talks only four days after they announced a potential tie up.
Puretech Health confirms possible tie-up with Ne... | 07-Oct-2022 | ShareCast |
Puretech Health confirms possible tie-up with Ne... | 07-Oct-2022 | ShareCast |
Nektar has wider first-quarter loss on Exubera c... | 08-May-2008 | BayArea.com |
Lilly Ends Effort to Develop an Inhaled Insulin ... | 08-Mar-2008 | New York Times |
Nektar cuts 150 jobs; operations chief steps down | 13-Feb-2008 | BayArea.com |
Business Digest | 24-May-2007 | BayArea.com |
Business Digest | 23-May-2006 | BayArea.com |
Did Pfizer's marketing fizzle? | 31-Aug-2007 | BayArea.com |
U.S. Regulators Approve Insulin in Inhaled Form | 28-Jan-2006 | New York Times |
FDA expected to OK inhaled form of insulin | 27-Jan-2006 | BayArea.com |
Stocks Mostly Listless; Dow Edges Down | 14-Jan-2006 | LA Times |
Hot Stocks to Watch for Friday, April 28, 2006: ... | 28-Apr-2006 | Marketwired |
Currency | US Dollars |
Share Price | $ 0.49 |
Change Today | $ -0.06 |
% Change | -11.14 % |
52 Week High | $1.83 |
52 Week Low | $0.47 |
Volume | 2 |
Shares Issued | 180.09m |
Market Cap | $88.32m |
RiskGrade | 333 |
Strong Buy | 2 |
Buy | 3 |
Neutral | 2 |
Sell | 1 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 131,386 @ $0.49 |
15:59 | 100 @ $0.49 |
15:59 | 100 @ $0.49 |
15:59 | 123 @ $0.49 |
15:59 | 100 @ $0.49 |
You are here: research